ZyVersa Therapeutics's total assets for Q2 2025 were $19.64B, an increase of 93493.54% from the previous quarter. ZVSA total liabilities were $13.54B for the fiscal quarter, a 105237.51% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.